CA3205053A1 - Systems, devices, and methods relating to medication dose guidance - Google Patents

Systems, devices, and methods relating to medication dose guidance

Info

Publication number
CA3205053A1
CA3205053A1 CA3205053A CA3205053A CA3205053A1 CA 3205053 A1 CA3205053 A1 CA 3205053A1 CA 3205053 A CA3205053 A CA 3205053A CA 3205053 A CA3205053 A CA 3205053A CA 3205053 A1 CA3205053 A1 CA 3205053A1
Authority
CA
Canada
Prior art keywords
dose
meal
time
data
processors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3205053A
Other languages
English (en)
French (fr)
Inventor
Gary A. Hayter
Aparajita BHATTACHARYA
Erwin S. Budiman
Matthew T. Novak
Taihao JIN
Marc B. Taub
Jonathan M. FERN
Yongjin Xu
Kaiyuan ZHU
Kendall COVINGTON
Kelly Cook
Jessica Rose FLOEH
Rosina BOSCO
Taylor M. CHARLESWORTH
Vyshnnavi Parthasarathy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of CA3205053A1 publication Critical patent/CA3205053A1/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA3205053A 2021-02-03 2022-02-02 Systems, devices, and methods relating to medication dose guidance Pending CA3205053A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163145131P 2021-02-03 2021-02-03
US63/145,131 2021-02-03
US202163225140P 2021-07-23 2021-07-23
US63/225,140 2021-07-23
US202163237769P 2021-08-27 2021-08-27
US63/237,769 2021-08-27
PCT/US2022/014920 WO2022169856A1 (en) 2021-02-03 2022-02-02 Systems, devices, and methods relating to medication dose guidance

Publications (1)

Publication Number Publication Date
CA3205053A1 true CA3205053A1 (en) 2022-08-25

Family

ID=80787465

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3205053A Pending CA3205053A1 (en) 2021-02-03 2022-02-02 Systems, devices, and methods relating to medication dose guidance

Country Status (5)

Country Link
EP (1) EP4288970A1 (https=)
JP (1) JP2024505285A (https=)
AU (1) AU2022216248A1 (https=)
CA (1) CA3205053A1 (https=)
WO (1) WO2022169856A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024252061A1 (en) * 2023-04-11 2025-11-20 WellDoc, Inc. Systems and methods for continuous glucose monitoring outcome predictions
US12251242B1 (en) 2023-10-24 2025-03-18 UpDoc Inc. Voice-based method and system for management of type 2 diabetes
WO2025165721A1 (en) 2024-01-30 2025-08-07 Abbott Diabetes Care Inc. Systems and methods for diabetes management
WO2025193785A1 (en) * 2024-03-13 2025-09-18 Abbott Diabetes Care Inc. Antihyperglycemic methods and systems

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
EP1918837A1 (en) * 2006-10-31 2008-05-07 F. Hoffmann-La Roche AG Method for processing a chronological sequence of measurements of a time dependent parameter
ES2881798T3 (es) 2010-03-24 2021-11-30 Abbott Diabetes Care Inc Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos
WO2014018928A1 (en) 2012-07-27 2014-01-30 Abbott Diabetes Care Inc. Medical device applicators
US10383580B2 (en) 2012-12-31 2019-08-20 Abbott Diabetes Care Inc. Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
CA2895538A1 (en) 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
US20170185748A1 (en) 2014-03-30 2017-06-29 Abbott Diabetes Care Inc. Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
US10806859B2 (en) * 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
WO2018132507A1 (en) 2017-01-11 2018-07-19 Abbott Diabetes Care Inc. Systems, devices, and methods for episode detection and evaluation with visit guides and action plans
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
WO2018152241A1 (en) 2017-02-15 2018-08-23 Abbott Diabetes Care Inc. Systems, devices, and methods for integration of an analyte data reader and medication delivery device
EP3586145A1 (en) 2017-02-21 2020-01-01 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
JP7512203B2 (ja) * 2017-12-12 2024-07-08 ビッグフット バイオメディカル インコーポレイテッド 治療支援情報及び/又は追跡装置並びに関連する方法及びシステム
US11464459B2 (en) * 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
EP3997712A4 (en) * 2019-07-09 2023-07-12 Eli Lilly And Company METHOD AND SYSTEM FOR DETERMINING A VARIATION IN GLYCEMIA IN A SUBJECT
MX2022001442A (es) 2019-08-02 2022-02-22 Abbott Diabetes Care Inc Sistemas, dispositivos y metodos relacionados con guia de dosis de medicamentos.

Also Published As

Publication number Publication date
AU2022216248A9 (en) 2025-01-30
WO2022169856A1 (en) 2022-08-11
AU2022216248A1 (en) 2023-07-27
JP2024505285A (ja) 2024-02-05
EP4288970A1 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
US12555660B2 (en) Systems, devices, and methods relating to medication dose guidance
US12424326B2 (en) Systems, devices, and methods for episode detection and evaluation
US20220249779A1 (en) Systems, devices, and methods relating to medication dose guidance
US20250191740A1 (en) Systems, devices, and methods for episode detection and evaluation with intervention guides, action plans and/or scheduling interfaces
EP3889965B1 (en) Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a device
EP2710502B1 (en) Dynamic data collection
US20220338803A1 (en) Systems and methods for diabetes management
CA3205053A1 (en) Systems, devices, and methods relating to medication dose guidance
US20120011125A1 (en) Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20120088989A1 (en) Management Method And System For Implementation, Execution, Data Collection, and Data Analysis of A Structured Collection Procedure Which Runs On A Collection Device
US20250342932A1 (en) Systems and methods for medication dosing and titration
CN117099165A (zh) 与药物剂量指导相关的系统、设备及方法
US20260076591A1 (en) Systems and methods for diabetes management
JP2025538349A (ja) 薬剤投与ガイダンスに関するシステム、デバイス、及び方法

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241221

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241221

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241221

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251217

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251217

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20260129

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20260129

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260129

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260227

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20260227

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260227

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260227

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260227

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260302